[go: up one dir, main page]

NO932731D0 - Nye isobutylsubstituerte metansulfonyl-kinolylmetoksy-fenyl-cykloalkyleddiksyreamider - Google Patents

Nye isobutylsubstituerte metansulfonyl-kinolylmetoksy-fenyl-cykloalkyleddiksyreamider

Info

Publication number
NO932731D0
NO932731D0 NO932731A NO932731A NO932731D0 NO 932731 D0 NO932731 D0 NO 932731D0 NO 932731 A NO932731 A NO 932731A NO 932731 A NO932731 A NO 932731A NO 932731 D0 NO932731 D0 NO 932731D0
Authority
NO
Norway
Prior art keywords
metansulphonyl
cycloalkyledic
chinolylmetoxy
amamids
phenyl
Prior art date
Application number
NO932731A
Other languages
English (en)
Other versions
NO932731L (no
NO179948B (no
NO179948C (no
Inventor
Siegfried Raddatz
Klaus-Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Reiner Mueller-Peddinghaus
Armin Hatzelmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO932731D0 publication Critical patent/NO932731D0/no
Publication of NO932731L publication Critical patent/NO932731L/no
Publication of NO179948B publication Critical patent/NO179948B/no
Publication of NO179948C publication Critical patent/NO179948C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO932731A 1992-08-12 1993-07-29 Nye isobutylsubstituerte metansulfonyl-kinolylmetoksyfenyl-cykloalkyleddiksyreamider og anvendelse av disse NO179948C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226649A DE4226649A1 (de) 1992-08-12 1992-08-12 Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole

Publications (4)

Publication Number Publication Date
NO932731D0 true NO932731D0 (no) 1993-07-29
NO932731L NO932731L (no) 1994-02-14
NO179948B NO179948B (no) 1996-10-07
NO179948C NO179948C (no) 1997-01-15

Family

ID=6465373

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932731A NO179948C (no) 1992-08-12 1993-07-29 Nye isobutylsubstituerte metansulfonyl-kinolylmetoksyfenyl-cykloalkyleddiksyreamider og anvendelse av disse

Country Status (19)

Country Link
EP (1) EP0582916A1 (no)
JP (1) JPH06157462A (no)
KR (1) KR940003937A (no)
CN (1) CN1039998C (no)
AU (1) AU669913B2 (no)
CA (1) CA2103600A1 (no)
CZ (1) CZ282341B6 (no)
DE (1) DE4226649A1 (no)
FI (1) FI933529L (no)
HU (1) HUT70171A (no)
IL (1) IL106623A0 (no)
MX (1) MX9304608A (no)
MY (1) MY108716A (no)
NO (1) NO179948C (no)
NZ (1) NZ248350A (no)
PL (1) PL174102B1 (no)
RU (1) RU2103261C1 (no)
SK (1) SK86693A3 (no)
ZA (1) ZA935828B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US5931170A (en) * 1998-10-08 1999-08-03 Addway Engineering Limited Dental flosser
US6441176B1 (en) * 1999-10-29 2002-08-27 Pfizer Inc. Method for preparing sodium-hydrogen exchanger type 1 inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren

Also Published As

Publication number Publication date
FI933529A7 (fi) 1994-02-13
DE4226649A1 (de) 1994-02-17
HU9302320D0 (en) 1993-10-28
HUT70171A (en) 1995-09-28
JPH06157462A (ja) 1994-06-03
AU669913B2 (en) 1996-06-27
PL174102B1 (pl) 1998-06-30
NO932731L (no) 1994-02-14
FI933529A0 (fi) 1993-08-10
RU2103261C1 (ru) 1998-01-27
ZA935828B (en) 1994-03-10
MX9304608A (es) 1994-02-28
NO179948B (no) 1996-10-07
SK86693A3 (en) 1994-09-07
KR940003937A (ko) 1994-03-14
CZ163693A3 (en) 1994-03-16
AU4425593A (en) 1994-02-17
CN1087084A (zh) 1994-05-25
NZ248350A (en) 1994-12-22
CN1039998C (zh) 1998-09-30
NO179948C (no) 1997-01-15
PL300025A1 (en) 1994-03-21
IL106623A0 (en) 1993-12-08
MY108716A (en) 1996-11-30
CA2103600A1 (en) 1994-02-13
FI933529L (fi) 1994-02-13
EP0582916A1 (de) 1994-02-16
CZ282341B6 (cs) 1997-07-16

Similar Documents

Publication Publication Date Title
NO303016B1 (no) Nye forbindelser
FI933260A7 (fi) Heteroaettiksyraderivat
NO930760D0 (no) Substituerte fenyleddiksyreamider
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
DK0509974T3 (da) Nye aktive forbindelser
FI943499A7 (fi) Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja
DE59305938D1 (de) Pyridyloxy-acrylsäureester
NO930722D0 (no) Imidazolylsubstituerte fenyleddiksyreamider
KR960700242A (ko) 8-메톡시퀴놀론카르복실산 유도체(8-methoxyquinolonecarboxylic acid derivative)
DE69317893D1 (de) Percarbonsäure
FI961872L (fi) 5-aryyli-isoksatsol-4-yyli substituoidut 2-aminokarboksyylihappoyhdisteet
FI933512A7 (fi) 2-substituerade kinolinylmetoxifenylaettiksyraderivat
FI932953A7 (fi) Imidazolylsubstituerade fenylpropion- och -kanelsyraderivat
FI930462A7 (fi) Aminobensoesyraderivat
NO922243L (no) Nye cefem-forbindelser
FI933300L (fi) Foerfarande foer rengoering av klorvaetesyra i gasform
NO932731D0 (no) Nye isobutylsubstituerte metansulfonyl-kinolylmetoksy-fenyl-cykloalkyleddiksyreamider
FI922125L (fi) Mikrobidogiskt foerfarande foer framstaellning av 5-hydroxipyrazinkarboxylsyra
FI925467A7 (fi) Kinolyylimetoksifenyylietikkahappoamidit
FI940040L (fi) Nonatetraeenihappojohdannainen
NO940195L (no) Nye forbindelser
NO932002D0 (no) Nye tiosemikarbazonsyreestere
NO924900L (no) Nye tiazoler
NO942051D0 (no) Nye tiosemikarbazontioner
DE69311355D1 (de) Persäure-verbindungen